Core Viewpoint - Shenzhen Benxin Pharmaceutical Technology Co., Ltd. has been established with a registered capital of 5 million RMB, fully owned by Livy Limited, indicating a strategic move in the pharmaceutical sector [1] Company Overview - The legal representative of Shenzhen Benxin Pharmaceutical Technology Co., Ltd. is Benjamin Ping Xu [1] - The company is classified as a limited liability company with foreign investment from Hong Kong, Macao, and Taiwan [1] - The business scope includes medical research and experimental development (excluding human stem cells, gene diagnosis, and treatment technology development and application), technology services, investment activities, enterprise management consulting, and import-export of goods and technology [1] Business Operations - The company is permitted to engage in drug production, subject to approval from relevant authorities [1] - The operational address is located at No. 16, High-tech Middle Road, Malin Community, Yuehai Street, Nanshan District, Shenzhen [1] - The business license allows for independent operation of activities not requiring prior approval [1] Financial Information - The registered capital of the company is 5 million RMB, which reflects its initial investment capacity [1]
深圳奔新医药科技有限公司成立，注册资本500万人民币
Sou Hu Cai Jing·2026-02-03 20:50